CTV vs. VTEX, OPRA, ENFN, COUR, BASE, AMPL, FSLY, DCBO, TUYA, and NYAX
Should you be buying Innovid stock or one of its competitors? The main competitors of Innovid include VTEX (VTEX), Opera (OPRA), Enfusion (ENFN), Coursera (COUR), Couchbase (BASE), Amplitude (AMPL), Fastly (FSLY), Docebo (DCBO), Tuya (TUYA), and Nayax (NYAX). These companies are all part of the "prepackaged software" industry.
VTEX (NYSE:VTEX) and Innovid (NYSE:CTV) are both small-cap computer and technology companies, but which is the better stock? We will compare the two companies based on the strength of their community ranking, profitability, analyst recommendations, dividends, media sentiment, institutional ownership, earnings, risk and valuation.
In the previous week, VTEX had 1 more articles in the media than Innovid. MarketBeat recorded 4 mentions for VTEX and 3 mentions for Innovid. Innovid's average media sentiment score of 0.36 beat VTEX's score of -0.24 indicating that VTEX is being referred to more favorably in the media.
VTEX received 4 more outperform votes than Innovid when rated by MarketBeat users. However, 66.67% of users gave Innovid an outperform vote while only 50.00% of users gave VTEX an outperform vote.
63.7% of VTEX shares are owned by institutional investors. Comparatively, 25.5% of Innovid shares are owned by institutional investors. 40.9% of VTEX shares are owned by company insiders. Comparatively, 9.9% of Innovid shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
VTEX has higher revenue and earnings than Innovid. VTEX is trading at a lower price-to-earnings ratio than Innovid, indicating that it is currently the more affordable of the two stocks.
VTEX has a beta of 1.41, suggesting that its stock price is 41% more volatile than the S&P 500. Comparatively, Innovid has a beta of 3.28, suggesting that its stock price is 228% more volatile than the S&P 500.
VTEX currently has a consensus price target of $8.79, indicating a potential upside of 28.07%. Innovid has a consensus price target of $2.70, indicating a potential upside of 22.73%. Given Innovid's stronger consensus rating and higher possible upside, equities analysts plainly believe VTEX is more favorable than Innovid.
VTEX has a net margin of -3.87% compared to VTEX's net margin of -20.24%. Innovid's return on equity of -3.32% beat VTEX's return on equity.
Summary
VTEX beats Innovid on 15 of the 18 factors compared between the two stocks.
Get Innovid News Delivered to You Automatically
Sign up to receive the latest news and ratings for CTV and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CTV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Related Companies and Tools